Building up financial exposure to a business you don’t control can be risky, but buying minority stakes does offer advantages ...
Colder evenings are drawing in, and living rooms are shifting from showpiece to shelter as households chase comfort without ...
Auna S.A. ("Auna" or the "Company"), a Latin American healthcare company with operations in Mexico, Peru and Colombia, today announced the pricing of U.S.$365,000,000 aggregate principal amount of ...
Stronger refining earnings will help offset declines in oil prices as the market appears to enter a period of significant oversupply ...
Developed by Ascentage Pharma, olverembatinib is the first China-approved third-generation BCR-ABL inhibitor, currently being jointly commercialized in China by Ascentage Pharma and Innovent Biologics ...